Emerging leader in cannabis-infused beverages BevCanna Enterprises Inc. (“BevCanna” or the “Company”) (CSE:BEV, Q:BVNNF, FSE:7BC) is excited to announce the debut of its latest cannabis-infused beverage brand, Jase™.

Created with an appealing pomegranate lemonade flavour, Jase will be available for sale in licensed dispensaries in California this year. Jase will be offered in a ready-to-mix single-serve powder, infused with 10 mg of THC, and available in 10-pouch box.


BevCanna Launches Jase™ Brand Cannabis-Infused Beverage Powder

The Jase brand distinctly evokes “California Cool” – the endless summer sun combined with a vibrant hedonism. The mood is upbeat. The style, bold. The attitude, confident.  Coined from “ganja”, the Sanskrit word for hemp or cannabis, and the word “base”, Jase suggests a brand that is approachable, upbeat and bold.

“When conducting our North-America wide consumer study, it was quickly apparent that lemonade was seen as one of most popular flavours,” said John Campbell, Chief Strategy Officer at BevCanna. “We were inspired by the idea of creating a vibrant, bold lemonade beverage that consumers could enjoy on sociable occasions, and we liked the idea of it being easily portable. Consumers can add the powder to their choice of still or sparking waters to create a personalized experience.”

Developed in response to BevCanna’s extensive North American-wide consumer study, which focused on product and consumption preferences within the cannabis-infused beverage market, Jase joins BevCanna’s roster of recently released ready to drink brands, including the Anarchist Mountain Beverages™ line of botanical-flavoured sparkling beverages and the Grüv Beverages™ line of iced teas.

Jase – Let’s shake thing up.

About BevCanna Enterprises Inc.
BevCanna Enterprises Inc. (CSE: BEV, Q:BVNNF, FSE:7BC) develops and manufactures cannabinoid-infused beverages and consumer products for in-house brands and white label clients. With decades of experience creating, branding and distributing iconic brands that have resonated with consumers on a global scale, the team demonstrates an expertise unmatched in the emerging cannabis beverage category. Based in British Columbia, Canada, BevCanna has a 292-acre outdoor cultivation site in the fertile Okanagan Valley and the exclusive rights to a pristine spring water aquifer, as well as a world-class 40,000-square-foot, HACCP certified manufacturing facility, with a current bottling capacity of up to 210M bottles.

On behalf of the Board of Directors:
John Campbell, Chief Financial Officer and Chief Strategy Officer
Director, BevCanna Enterprises Inc.

Disclaimer for Forward-Looking Information

This news release contains forward-looking statements under applicable securities laws, including the statements that Jase will be available for sale in licensed dispensaries in California this year and will be offered in a ready-to-mix single-serve powder, infused with 10 mg of THC, and available in 10-pouch box. These statements are based on certain assumptions regarding the future business plans of the Company. Readers are cautioned not to place undue reliance on forward-looking statements. The assumptions of the Company, although considered reasonable by it at the time of preparation, may prove to be incorrect. In addition, forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with future legislative and regulatory developments in Canada and the United States; adverse market conditions; and other factors beyond the control of the Company. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Click here to connect with BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) for an Investor Presentation

Source

Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=aurora-cannabis-inc&id=2437 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less